NCT00812318View on ClinicalTrials.gov

Healthy Volunteer Study To Assess The Bioavailability of GSK1265744 When Administered Orally Either When Fasted or Following a Meal.

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
HIV InfectionInfection, Human Immunodeficiency Virus
Interventions
DRUG

GSK1265744 10 mg oral solution

GSK1265744

DRUG

GSK1265744 5 mg tablet

GSK1265744 5mg tablet, fasted

DRUG

GSK1265744 5 mg tablet

GSK1265744 5mg tablet, fed

Trial Locations (1)

14202

GSK Investigational Site, Buffalo

Sponsors

Lead Sponsor

ViiV Healthcare

Collaborators (2)

Shionogi
GlaxoSmithKline
All Listed Sponsors
collaborator

Shionogi

INDUSTRY

collaborator

GlaxoSmithKline

INDUSTRY

lead

ViiV Healthcare

INDUSTRY